Production of extended-spectrum beta-lactamases in Escherichia coli isolated from poultry in Rio de Janeiro, Brazil. [PDF]
Patricio TCDC +8 more
europepmc +1 more source
Two novel lytic Enterobacter phages, HHH and RZH, displayed targeted antibiofilm activity against MDR Enterobacter cloacae complex biofilms when combined with EDTA. Activity was strongest within a narrow low‐millimolar EDTA window, reducing biofilm biomass and viable burden, while higher EDTA concentrations shifted the interaction towards antagonism ...
Kashif Haq +4 more
wiley +1 more source
Molecular epidemiology and antimicrobial resistance of extended-spectrum beta-lactamases-producing <i>Enterobacter cloacae</i> complex among mothers, neonates, healthcare workers and hospital environments in Tanga, Tanzania. [PDF]
Mhina AD +16 more
europepmc +1 more source
Using a combination of short- and long-read sequencing to investigate the diversity in plasmid- and chromosomally encoded extended-spectrum beta-lactamases (ESBLs) in clinical Shigella and Salmonella isolates in Belgium. [PDF]
Berbers B +5 more
europepmc +1 more source
Whole‐genome sequencing analysis of Escherichia coli isolates from broiler, layer and sonali chickens in Bangladesh shown extensive antimicrobial resistance, diverse virulence factors, plasmid‐mediated resistance, and a highly open pangenome. Comparative genomic analyses demonstrated close genetic relationships with global strains, highlighting the One
Md. Rokibul Hasan Shanto +6 more
wiley +1 more source
Study of extended-spectrum beta-lactamases and AmpC beta-lactamases producing <i>Klebsiella</i> from clinical samples in tertiary care hospital of Punjab. [PDF]
Kaur H +4 more
europepmc +1 more source
Antimicrobial resistance including Extended Spectrum Beta Lactamases (ESBL) among E. coli isolated from kenyan children at hospital discharge. [PDF]
Tornberg-Belanger SN +15 more
europepmc +1 more source
Iran's Escherichia coli AMR Landscape (2010–2025): A One Health Systematic Review and Meta‐Analysis
This One Health systematic review and meta‐analysis of 368 studies (2010–2025) reveals that 47.2% of E. coli isolates in Iran are ESBL‐producers, with alarming resistance to penicillins, cephalosporins, and fluoroquinolones. Critically, resistance to last‐resort antibiotics—colistin and ertapenem—is significantly increasing over time.
Arezoo Dehghan +9 more
wiley +1 more source

